Holen Sie sich die Stockscreener-App
61.27
0.68%
-0.42
Vorhandelsmarkt:
61.35
0.08
+0.13%
Schlusskurs vom Vortag:
$61.69
Offen:
$60.94
24-Stunden-Volumen:
474.71K
Relative Volume:
0.49
Marktkapitalisierung:
$1.77B
Einnahmen:
$915.25M
Nettoeinkommen (Verlust:
$131.14M
KGV:
13.70
EPS:
4.472
Netto-Cashflow:
$96.71M
1W Leistung:
+5.27%
1M Leistung:
+15.02%
6M Leistung:
+2.92%
1J Leistung:
-34.15%
1-Tages-Spanne:
$58.00
$62.20
1-Wochen-Bereich:
$55.44
$62.20
52-Wochen-Spanne:
$38.91
$147.03
Inspire Medical Systems Inc Stock (INSP) Company Profile
Firmenname
Inspire Medical Systems Inc
Sektor
Branche
Telefon
763-957-5037
Adresse
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
61.27 | 1.78B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-13 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2026-01-22 | Herabstufung | Truist | Buy → Hold |
| 2025-12-08 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2025-12-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | Hochstufung | Truist | Hold → Buy |
| 2025-11-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | Hochstufung | Stifel | Hold → Buy |
| 2025-11-04 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2025-09-02 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | Herabstufung | Truist | Buy → Hold |
| 2024-11-20 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-04-19 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-03-19 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2024-01-02 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-04-14 | Eingeleitet | Mizuho | Buy |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-12-13 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2022-04-06 | Eingeleitet | Wolfe Research | Peer Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-11-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-11-03 | Hochstufung | Oppenheimer | Underperform → Perform |
| 2020-09-22 | Eingeleitet | JP Morgan | Overweight |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-08-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-07-15 | Eingeleitet | Goldman | Buy |
| 2020-06-18 | Bestätigt | Piper Sandler | Overweight |
| 2020-05-18 | Eingeleitet | Lake Street | Buy |
| 2020-04-28 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-28 | Eingeleitet | Oppenheimer | Underperform |
| 2020-01-27 | Eingeleitet | Oppenheimer | Underperform |
| 2019-11-06 | Hochstufung | Berenberg | Sell → Hold |
| 2019-02-05 | Eingeleitet | Dougherty & Company | Buy |
| 2018-11-28 | Eingeleitet | Berenberg | Sell |
| 2018-10-29 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-29 | Eingeleitet | Guggenheim | Buy |
| 2018-05-29 | Eingeleitet | Stifel | Buy |
| 2018-05-29 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Inspire Medical Systems Inc Aktie (INSP) Neueste Nachrichten
Here's Why You Should Add INSP Stock to Your Portfolio Now - TradingView
Inspire Medical Systems (NYSE:INSP) Stock Rating Upgraded by Zacks Research - MarketBeat
Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript - AOL.com
GSA Capital Partners LLP Purchases New Stake in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems (INSP) Stock Trades Below Fair Value As Caution Lingers - Sahm
Alberta Investment Management Corp Takes $5.48 Million Position in Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating the Sleep Apnea Market with a 5.78% Upside Potential - DirectorsTalk Interviews
Inspire Medical Systems (INSP) Stock May Be Cheap After A 74% Fall - Yahoo Finance
Inspire Medical Systems (INSP) Updates Guidance As Valuation Questions Persist - Sahm
Which Medtech Giant Would Buy Inspire Medical Systems? - Trefis
Inspire Medical Systems (INSP): Soleus Capital group reports 6.7% ownership stake - Stock Titan
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo Finance
AQR Capital discloses 6.44% Inspire Medical Systems (INSP) ownership on Schedule 13G - Stock Titan
Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Inspire medical systems chief mfg. officer Kelly sells $57,346 in stock - Investing.com Australia
Inspire medical systems chief mfg. officer Kelly sells $57,346 in stock By Investing.com - Investing.com India
Inspire Medical Systems (NYSE:INSP) Insider Jason Kelly Sells 963 Shares of Stock - MarketBeat
Inspire Medical Systems (INSP) officer Jason P. Kelly sells 963 shares at $59.55 - Stock Titan
Inspire Medical Systems (INSP) Is Up 19.8% After Q2 Profit And Higher 2026 GuidanceHas The Bull Case Changed? - webull.com
5 Insightful Analyst Questions From Inspire Medical Systems’s Q2 Earnings Call - Yahoo Finance
Janus Henderson Group PLC Sells 548,880 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Price to sales ratio of Inspire Medical Systems, Inc. – HAM:2DR - TradingView
Operating margin % of Inspire Medical Systems, Inc. – HAM:2DR - TradingView
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Market Volatility with Strong Growth Potential - DirectorsTalk Interviews
INSP Should I Buy - Intellectia AI
INSP.N PE Ratio & Valuation, Is INSP.N Overvalued - Intellectia AI
Dimensional Fund Advisors LP Trims Holdings in Inspire Medical Systems, Inc. $INSP - marketbeat.com
Assenagon Asset Management S.A. Increases Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Class Action Lawsuit Filed Against Inspire Medical Systems, Inc - The National Law Review
Inspire Medical Systems, Inc. $INSP Shares Bought by Royal Bank of Canada - marketbeat.com
Inspire Medical Systems, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:INSP) 2026-08-07 - Seeking Alpha
Inspire Medical Systems, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Empowered Funds LLC Makes New Investment in Inspire Medical Systems, Inc. $INSP - MarketBeat
Lost Money on Inspire Medical Systems, Inc. (INSP)? Urged to Join - The National Law Review
Inspire Medical Systems, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Lazard Asset Management LLC Cuts Stock Position in Inspire Medical Systems, Inc. $INSP - marketbeat.com
First Trust Advisors LP Has $3.70 Million Position in Inspire Medical Systems, Inc. $INSP - MarketBeat
INSP Raises 2026 Outlook as Reimbursement Headwinds Start to Ease - TradingView
Is INSP a Buy as Margins Improve but Reimbursement Risks Persist? - finance.yahoo.com
Inspire Medical Systems (INSP) Stock May Be A Bargain On Raised 2026 Guidance - Sahm
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors - Yahoo Finance
UBS Adjusts Inspire Medical Systems Price Target to $40 From $39, Maintains Sell Rating - finance.yahoo.com
Amundi Sells 107,792 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
Inspire Medical Systems (NYSE: INSP) files Form 4 on RSU tax withholding - stocktitan.net
JPMorgan Chase & Co. Increases Inspire Medical Systems (NYSE:INSP) Price Target to $60.00 - MarketBeat
INSP Price Today: Inspire Medical Systems, Inc. Stock Price, Quote & Chart | MEXC - mexc.co
Mizuho Boosts Inspire Medical Systems (NYSE:INSP) Price Target to $65.00 - MarketBeat
Inspire Medical Q2 Earnings Beat Estimates, '26 View Raised, Stock Up - Yahoo Finance
Inspire Medical Systems, Inc. Stock 12‑Month Price Target Raised to $60.33, Implies 16% Upside - TradingView
Why Are Inspire Medical Systems (INSP) Shares Soaring Today - barchart.com
Inspire Medical surges on revised guidance, earnings, Street upgrade - Seeking Alpha
Finanzdaten der Inspire Medical Systems Inc-Aktie (INSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):